Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma

Clinical trial NCT04757662 · COMPLETED

Trial details

NCT number: NCT04757662
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Grade III Astrocytoma Grade IV Astrocytoma Astrocytoma, Grade IV Astrocytoma, Grade III

Start date: 2021-05-14
Primary completion: 2023-06-07
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.